IP Verse

Argentum Pharmaceuticals LLC et al. v. Janssen Oncology, Inc. et al. - IPR2016-01317

Explore the PTAB proceeding IPR2016-01317 filed by Argentum Pharmaceuticals LLC et al. against Janssen Oncology, Inc. et al. on Jun 29, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2016-01317
Filing Date
Jun 29, 2016
Petitioner
Argentum Pharmaceuticals LLC et al.
Respondent
Janssen Oncology, Inc. et al.
Status
Final Written Decision
Respondent Application Number
13034340
Respondent Tech Center
1600
Respondent Patent Number
8822438
Institution Decision Date
Sep 19, 2016
Termination Date
Jan 17, 2018

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2016-01317.

TypeName
Petitioner CounselTeresa Rea
Respondent CounselDianne Elderkin

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.